non
on 22 Dec 2023
Last Applicant/ Owned by
SUITE 650
RADNOR
PA
19087
Serial Number
88916847 filed on 14th May 2020
Registration Number
N/A
Correspondent Address
Thomas G. Peterson
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
"THERAPEUTICS"
"THERAPEUTICS" Housemark for a full line of prescription pharmaceuticals for the treatment of cancer, multiple sclerosis, cystic fibrosis, and tuberous sclerosis complex; pharmaceuticals for treatment of cancer, multiple sclerosis, cystic fibrosis, and tuberous sclerosis complex; pharmaceuticals exhibiting efficient drug release for the treatment of cancer, multiple sclerosis, cystic fibrosis, anRead More
Housemark for a full line of prescription pharmaceuticals for the treatment of cancer, multiple sclerosis, cystic fibrosis, and tuberous sclerosis complex; pharmaceuticals for treatment of cancer, multiple sclerosis, cystic fibrosis, and tuberous sclerosis complex; pharmaceuticals exhibiting efficient drug release for the treatment of cancer, multiple sclerosis, cystic fibrosis, and tuberous sclerosis complex
01st Dec 2020
01st Dec 2020
No 88916847
No Service/Collective Mark
No 825586.00001
No
No
No
No
No
No
No
No
| Status Date | Action Taken |
|---|---|
| 19th Mar 2024 | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED |
| 19th Mar 2024 | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED |
| 22nd Dec 2023 | SU - NON-FINAL ACTION - WRITTEN |
| 22nd Dec 2023 | NON-FINAL ACTION E-MAILED |
| 22nd Dec 2023 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| 13th Dec 2023 | STATEMENT OF USE PROCESSING COMPLETE |
| 08th Dec 2023 | TEAS STATEMENT OF USE RECEIVED |
| 08th Dec 2023 | USE AMENDMENT FILED |
| 15th Sep 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 14th Sep 2023 | SOU EXTENSION 5 GRANTED |
